drugset / Trial / NCT00438100
Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To investigate and compare the efficacy and safety of S-1 vs. Capecitabine as primary chemotherapy in patients with inoperable or recurrent breast cancer.
Timeline
- Start
- 2008-04
- Primary completion
- 2012-07
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Capecitabine | Small molecule | 1600 mg/m2 | Oral |
| Subject | S-1 | Small molecule | 80 mg/m2 | Oral |